Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience

BACKGROUND: The aim of the study is to evaluate the role of cytoreductive nephrectomy (CN) with thrombectomy before targeted molecular therapy (TMT) on survival in metastatic renal cell carcinoma (mRCC) with venous tumor thrombus. METHODS: We performed a retrospective analysis of 47 patients treated...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :World J Surg Oncol
Главные авторы: Qi, Nienie, Wu, Pengjie, Chen, Jinchao, Li, Teng, Ning, Xianghui, Wang, Jin, Gong, Kan
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2017
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217450/
https://ncbi.nlm.nih.gov/pubmed/28056988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-1066-3
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы